The comprehensive InPractice reference for diagnosing, monitoring and treating CLL is regularly updated, with the latest update incorporating the addition of ofatumumab to idelalisib in patients with relapsed/refractory CLL plus the initial results from HELIOS trial of ibrutinib added to BR. The authors are Jacqueline Barrientos and Kanti Rai, (of Rai CLL staging fame). You'll need to register (free) to access the site, but it's well worth bookmarking for quick reference: inpractice.com/Textbooks/On...
Updated Ibrutinib + ofatumumab entry:
You can see what changes have been made here over the last 6 years:
Year Updates Changes
2015_____2__________5 (to date)
If you were in any doubt regarding the recent incredible progress on treating CLL, just look at the difference in how often this CLL reference document has been updated in recent years compared to earlier in the document's history!
Photo: At this time of year, the brilliant yellow flowers of the canola (rapeseed) crops provide a startling contrast in the countryside.